|
|
Article: Greer Sponsors Landmark Study Analyzing the Benefits and Cost Effectiveness of Allergy Immunotherapy among Children with Allergic Rhinitis.
- Article from:
- Business Wire
- Article date:
- February 5, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Study Findings Published in The Journal of Allergy and Clinical Immunology Provide Unique Perspective on the Benefits of Allergy Immunotherapy
LENOIR, N.C. -- Greer, a leading developer and provider of allergy immunotherapy products and services, provided a grant to BioMedEcon to conduct a retrospective study analyzing the use of allergy immunotherapy via subcutaneous injections in children with allergic rhinitis. The study analyzed Medicaid records of 520 low-income Florida children with documented allergies. According to the study, published in the January issue of The Journal of Allergy and Clinical Immunology (JACI), the use of allergy immunotherapy delivers ...